U.S. Markets open in 8 hrs 5 mins

Valeant Pharmaceuticals before Its Q2 2018 Earnings

Daniel Collins
Valeant Pharmaceuticals before Its Q2 2018 Earnings

Valeant Pharmaceuticals (VRX), now known as Bausch Health Companies (BHC), generated revenues of $2 billion in the first quarter compared to $2.1 billion in the first quarter of 2017, reflecting a 5% YoY (year-over-year) decline.